A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ASCENDING-DOSE, SAFETY STUDY OF CC-220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引:1
|
作者
Werth, V. P. [1 ]
Furie, R. [2 ]
Korish, S. [3 ]
Weiswasser, M. [3 ]
Azaryan, A. [3 ]
Schafer, P. H. [3 ]
Delev, N. [3 ]
Choi, S. [3 ]
Hough, D. [3 ]
机构
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Northwell Hlth, Great Neck, NY USA
[3] Celgene Corp, Summit, NJ USA
关键词
D O I
10.1136/annrheumdis-2017-eular.3546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0255
引用
收藏
页码:870 / 871
页数:2
相关论文
共 50 条
  • [1] A Randomized, Placebo-Controlled, Double-Blind, Ascending-Dose, Safety, and Pharmacokinetics Study of CC-220 in Subjects with Systemic LUPUS Erythematosus
    Furie, Richard
    Werth, Victoria P.
    Gaudy, Allison
    Ye, Ying
    Korish, Shimon
    Azaryan, Ada
    Delev, Nikolay
    Hough, Douglas
    Weiswasser, Michael
    Choi, Suktae
    Schafer, Peter
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ASCENDING DOSE STUDY TO EVALUATE EFFICACY, SAFETY, AND TOLERABILITY OF CC 220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Furie, R.
    Werth, V. P.
    Lee, E.
    Box, E.
    Fondal, M.
    Kivitz, A.
    Chatham, W. W.
    Kalunian, K. C.
    Legerton, C.
    Anolik, J. H.
    Korish, S.
    Hough, D. R.
    Weiswasser, M.
    Choi, S.
    Schafer, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S77 - S77
  • [3] A phase 2, randomized, placebo-controlled, double-blind, ascending dose study to evaluate efficacy, safety, tolerability, pharmacokinetics, pharmacodynamics & pharmacogenetics of CC-220 in subjects with SLE
    Werth, V.
    Furie, R.
    Hough, D.
    Korish, S.
    Weiswasser, M.
    Azarian, A.
    Schafer, P.
    Delev, N.
    Choi, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S65 - S65
  • [4] Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
    Furie, Richard A.
    Hough, Douglas R.
    Gaudy, Allison
    Ye, Ying
    Korish, Shimon
    Delev, Nikolay
    Weiswasser, Michael
    Zhan, Xiaojiang
    Schafer, Peter H.
    Werth, Victoria P.
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [5] A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple, Intravenous, Ascending-Dose Study of Sirukumab in Patients with Cutaneous or Systemic Lupus Erythematosus.
    Szepietowski, Jacek C.
    Nilganuwong, Surasak
    Wozniacka, Anna
    Kuhn, Annegret
    Nyberg, Filippa
    Szechinski, Jacek
    van Vollenhoven, Ronald F.
    Bengtsson, Anders
    Reich, Adam
    de Vries, Dick
    van Hartingsveldt, Bart
    Zhou, Bei
    Hsu, Benjamin
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S496 - S497
  • [6] Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study
    Alvarez-Nemegyei, J
    Cobarrubias-Cobos, A
    Escalante-Triay, F
    Sosa-Munoz, J
    Miranda, JM
    Jara, LJ
    LUPUS, 1998, 7 (06) : 414 - 419
  • [7] Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus
    Tam, LS
    Li, EK
    Wong, CK
    Lam, CWK
    Szeto, CC
    LUPUS, 2004, 13 (08) : 601 - 604
  • [8] Bromocriptine in systemic lupus erythematosus: A double-blind, randomized placebo-controlled study.
    AlvarezNemegyei, J
    CovarrubiasCobos, A
    EscalanteTriay, F
    SosaMunoz, G
    Jara, LJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1351 - 1351
  • [9] Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled Trial
    Petri, Michelle
    Naqibuddin, Mohammad
    Sampedro, Margaret
    Omdal, Roald
    Carson, Kathryn A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) : 194 - 202
  • [10] Phase I, Randomized, Double-Blind, Placebo-Controlled, Multiple Intravenous, Dose-Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus
    Szepietowski, Jacek C.
    Nilganuwong, Surasak
    Wozniacka, Anna
    Kuhn, Annegret
    Nyberg, Filippa
    van Vollenhoven, Ronald F.
    Bengtsson, Anders A.
    Reich, Adam
    de Vries, Dick E.
    van Hartingsveldt, Bart
    Robinson, Donald W., Jr.
    Gordon, Robert
    Hsu, Benjamin
    ARTHRITIS AND RHEUMATISM, 2013, 65 (10): : 2661 - 2671